Abridge (ABRI.PVT)
Forge Price is a derived data point that reflects the up-to-date price performance of venture-backed, late-stage companies. Forge Price is calculated by Forge Data based on a proprietary model incorporating pricing inputs from publicly-available primary funding round information, secondary market transactions and indications of interest on Forge and other private market trading platforms. Forge Price is not a quotation, and does not indicate available supply or demand, is solely for informational purposes, and may rely on limited data.
Learn more- Estimated Valuation 5.85B
- Latest Funding Date Jun 24, 2025
- Total Amount Raised 773.91M
- Latest Amount Raised 315.93M
- Total Funding Rounds 7
- Latest Share Class Series E
Abridge: Learn More
Interested in exploring private markets? Connect with our partners.
Since 2013, EquityZen, a subsidiary of Morgan Stanley, has welcomed investors to private markets. Whether investing $5K or $5M, clients trust us with billions of dollars to access the most sought-after, innovative private companies.
Learn more at EquityZen
Forge, a subsidiary of The Charles Schwab Corporation (SCHW), is the trusted platform for buying and selling pre-IPO shares. Investors and shareholders worldwide rely on our deep data insights, liquidity solutions, and tailored investment opportunities to navigate the private market.
Learn more at ForgeAbridge Overview
Abridge develops generative AI technology designed to automate clinical documentation by recording and summarizing medical conversations directly into Electronic Medical Records (EMRs). The company aims to reduce administrative burdens for healthcare providers, thereby allowing clinicians to focus primarily on patient care.
2018-01-01
Founded
251
Full Time Employees
Software
Sector
Artificial Intelligence (AI), Health Care, Intelligent Systems, Machine Learning, Medical
Industry
Leadership and Board
Kim Walsh
Advisor
Sara Holoubek
Angel Investor
Zen Chu
Board Director
Julia Chou Chapin
COO
Zachary Lipton
CSO
Tina Shah
Chief Clinical Officer
Shivdev Rao
Co-Founder, CEO
Recent News
Performance Overview
Trailing returns as of 8/5/2026. Benchmark is Forge Private Market Index (^FPMI) .
3M Return
YTD Return
1-Year Return
2-Year Return
Valuation Information
Funding Rounds
Forge Data collects the preferred stock details for companies from the Certificates of Incorporation and related documents filed with relevant state's agencies. These documents authorize the various equity types available for companies to sell in primary funding rounds.
Funding Rounds
Forge Data collects the preferred stock details for companies from the Certificates of Incorporation and related documents filed with relevant state's agencies. These documents authorize the various equity types available for companies to sell in primary funding rounds.
Post-Money Valuation
Sep
2020
Apr
2022
Nov
2023
Jun
2025
Funding Date | Share Class | Amount Raised | Issue Price | Post-Money Valuation |
|---|---|---|---|---|
| 2025-06-24 | Series E | 315.93M | 158.4822 | 5.3B |
| 2025-02-17 | Series D | 250M | 90.0098 | 2.75B |
| 2024-02-23 | Series C | 150M | 33.1293 | 850M |
| 2023-10-26 | Series B | 30M | 10.9653 | 232.25M |
| 2022-08-11 | Series A-1 | 12.5M | 8.8159 | 144.48M |
| 2020-10-06 | Series A | 10.16M | 4.7695 | 102.98M |
| 2019-02-14 | Series Seed | 5.32M | 2.4307 | 26.59M |